If you have type 1 or type 2 diabetes, your doctor might prescribe Toujeo. It’s a prescription diabetes medication used in adults and some children. To learn more about diabetes and how Toujeo is used ...

Toujeo is a long-acting form of insulin. It works by lowering the level of blood sugar in the body. It is not used for diabetic ketoacidosis. Toujeo is given as a subcutaneous injection. For ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

Toujeo (insulin glargine) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat type 1 or type 2 diabetes. The drug is for use in adults as well as ...

The US Food and Drug Administration (FDA) has expanded the indication for Toujeo (insulin glargine 300 units/mL injection; Sanofi) to include children as young as 6 years of age with type 1 and type 2 ...

The FINANCIAL — Sanofi announced on February 26 that the U.S. Food and Drug Administration (FDA) approved Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal ...

SANOFI'S NEW BASAL INSULIN LANTUS XR, KNOWN AS TOUJEO IN THE U.S. AND EUROPE, APPROVED IN JAPAN FOR THE TREATMENT OF DIABETES MELLITUS Paris, France - July 3, 2015 - Sanofi announced today that the ...

Toujeo (insulin glargine) is a prescription drug used to help manage blood sugar in people with type 1 or type 2 diabetes. Toujeo can cause side effects that range from mild to serious, such as weight ...